Yvonne Suessmuth

1.0k total citations
14 papers, 344 citations indexed

About

Yvonne Suessmuth is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Yvonne Suessmuth has authored 14 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 6 papers in Immunology and 4 papers in Genetics. Recurrent topics in Yvonne Suessmuth's work include Hematopoietic Stem Cell Transplantation (6 papers), Immune Cell Function and Interaction (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yvonne Suessmuth is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Immune Cell Function and Interaction (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yvonne Suessmuth collaborates with scholars based in United States, United Kingdom and Australia. Yvonne Suessmuth's co-authors include Joanne Elliott, James A. Johnston, Ultan F. Power, Nigel J. Stevenson, James A. Johnston, Massimo Gadina, Caroline R. Boyd, James F. Burrows, Stefan N. Constantinescu and Richard Buick and has published in prestigious journals such as Blood, Journal of Virology and British Journal of Haematology.

In The Last Decade

Yvonne Suessmuth

12 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yvonne Suessmuth United States 6 119 116 115 112 93 14 344
Andrea Kuck Germany 6 192 1.6× 71 0.6× 208 1.8× 42 0.4× 43 0.5× 9 497
Alexandra Salmon France 13 97 0.8× 70 0.6× 86 0.7× 181 1.6× 126 1.4× 23 446
Victoria Campbell United States 10 54 0.5× 75 0.6× 119 1.0× 60 0.5× 105 1.1× 23 346
Elisangela Santos-Valente Austria 10 376 3.2× 61 0.5× 86 0.7× 45 0.4× 62 0.7× 12 503
Nana Yaa Mensah United States 4 81 0.7× 123 1.1× 112 1.0× 90 0.8× 25 0.3× 5 352
Joanne C. Porter United States 7 174 1.5× 35 0.3× 82 0.7× 101 0.9× 74 0.8× 12 412
Patricia Koenig United States 9 193 1.6× 188 1.6× 84 0.7× 39 0.3× 338 3.6× 12 637
Masamune Higashigawa Japan 11 42 0.4× 43 0.4× 136 1.2× 49 0.4× 58 0.6× 55 355
Hitoshi Hanamoto Japan 9 249 2.1× 45 0.4× 68 0.6× 21 0.2× 146 1.6× 29 422
Lesley Shield United Kingdom 12 172 1.4× 47 0.4× 74 0.6× 90 0.8× 377 4.1× 17 568

Countries citing papers authored by Yvonne Suessmuth

Since Specialization
Citations

This map shows the geographic impact of Yvonne Suessmuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Suessmuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Suessmuth more than expected).

Fields of papers citing papers by Yvonne Suessmuth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Suessmuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Suessmuth. The network helps show where Yvonne Suessmuth may publish in the future.

Co-authorship network of co-authors of Yvonne Suessmuth

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Suessmuth. A scholar is included among the top collaborators of Yvonne Suessmuth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Suessmuth. Yvonne Suessmuth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Davis, Carolyn, Caitlin A. Fitzgerald, Timothy K. Lee, et al.. (2025). The Role of Epidermal Growth Factor in Mediating Survival in Mouse Sepsis is Dependent Upon an Intact Adaptive Immune System. Shock. 64(6). 547–559.
2.
Bratrude, Brandi, Yvonne Suessmuth, Scott Gillespie, et al.. (2023). Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. Blood Advances. 7(16). 4395–4399. 4 indexed citations
3.
Stenger, Elizabeth, Benjamin Watkins, Kuang‐Yueh Chiang, et al.. (2023). Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure. Blood Advances. 7(10). 2196–2205. 12 indexed citations
4.
Bratrude, Brandi, Kayla Betz, Yvonne Suessmuth, et al.. (2023). Abatacept for the Prevention of Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis. Transplantation and Cellular Therapy. 29(2). S257–S257. 1 indexed citations
5.
Albanese, Alexandre, Kayla Betz, Yvonne Suessmuth, et al.. (2022). Single-Cell RNA-Seq Reveals an Interferon-Driven Inflammatory CD4 Naïve T Cell Subpopulation at Day 100 in Hematopoietic Stem Cell Transplant Patients That Ultimately Develop Chronic Gvhd. Blood. 140(Supplement 1). 270–271. 3 indexed citations
6.
Bratrude, Brandi, Kayla Betz, Yvonne Suessmuth, et al.. (2022). Abatacept for the Prevention of Gvhd in Pediatric and Adult Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis. Blood. 140(Supplement 1). 7653–7655. 3 indexed citations
7.
Suessmuth, Yvonne, Kayla Betz, Alison Yu, et al.. (2020). Potent Interaction between CMV Reactivation and Gvhd: Immunologic Evidence for Blunting of CMV-Driven Immune Reconstitution in the Setting of Gvhd. Blood. 136(Supplement 1). 50–50. 1 indexed citations
8.
Qayed, Muna, Thomas F. Cash, Mourad Tighiouart, et al.. (2019). A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatric Blood & Cancer. 67(4). e28134–e28134. 22 indexed citations
9.
Suessmuth, Yvonne, Divya Koura, Knut Finstermeier, et al.. (2015). Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire. Biology of Blood and Marrow Transplantation. 21(2). S69–S70. 1 indexed citations
10.
Elliott, Joanne, Yvonne Suessmuth, Latanya M. Scott, et al.. (2009). SOCS3 TYROSINE PHOSPHORYLATION AS A BIG-MARKER FOR THE MYELOPROLIFERATIVE DISORDER-ASSOCIATED MUTANT JAK2 KINASES. Haematologica. 94. 358–358. 1 indexed citations
11.
Suessmuth, Yvonne, Joanne Elliott, Melanie J. Percy, et al.. (2009). A new polycythaemia vera‐associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses. British Journal of Haematology. 147(4). 450–458. 19 indexed citations
12.
Suessmuth, Yvonne, Linda M. Scott, Mary Frances McMullin, et al.. (2009). SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases. Haematologica. 94(4). 576–580. 22 indexed citations
13.
Elliott, Joanne, Oonagh T. Lynch, Yvonne Suessmuth, et al.. (2007). Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase. Journal of Virology. 81(7). 3428–3436. 154 indexed citations
14.
Hookham, Michelle B., Joanne Elliott, Yvonne Suessmuth, et al.. (2007). The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood. 109(11). 4924–4929. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026